Companies & Industry »Company News»Company News Details
Company News Details

BSE   27 Apr 15 | 12:00 AM

1701.35 -64.9 (-3.67%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: 532321
Face Value: N.A.

NSE   27 Apr 15 | 12:00 AM

1701.80 -65.7 (-3.72%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: CADILAHC
Performance
1 Week : Rs 1,753.90 (-3.00%)
1 Month : Rs 1,661.20 (2.42%)
1 Year : Rs 982.45 (73.17%)
change companytradenow
Back

Cadila's stock rising: Credit Suisse

Reuters / 18 Jul 12 | 11:50 AM

Credit Suisse initiates coverage on Cadila Healthcare with an "outperform" rating and a target price of Rs 970.

Investment bank says the midcap drug maker has demonstrated "strong execution" in the United States, with a portfolio mix focusing on low competition products such as nasal sprays and injectable drugs.

USFDA approval of its facilities in Moraiya, part of Gujarat, will re-start new approvals of its drugs in the US market, Credit Suisse adds.

"Cadila is moving up the value-chain with the launch of difficult-to formulate products and its strong execution record provides multi-year growth visibility."

Sensex

Company Price Gain (%)
Maruti Suzuki3,646.703.02
Sesa Sterlite209.902.37
Wipro533.101.91
Coal India377.700.41
Tata Motors517.300.39

Online Portfolio

You can create Online Portfolio here using the below button.